͵͵

Annual Meeting

Stressed out? The cancer playbook may help

Learn about the session on stress adaptations in tumor progression in the Maximizing Access Committee’s symposium at Discover BMB 2024
Jonathan A. Kelber
By Jonathan A. Kelber
Sept. 14, 2023

We often associate the concept of stress with deadlines, emergencies, traffic or hardships. For those who study biological and biochemical processes of disease in cell and organismal models, the idea of stress adaptation is recognized as one mechanism by which malignant and nonmalignant cells survive and thrive within environments that, at times, are hostile.

Are there ways that we think about environmental stress adaptations at an organismal level that may help scientists develop new perspectives on combatting cancer to improve patient outcomes? Indeed, cancer cells may even engage in molecular decision-making activities that differentiate between fight-or-flight responses in the face of environmental stress.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.

This session will consider the mechanisms by which cancer cells adapt to intrinsic and extrinsic stressors and how defining these adaptative mechanisms may lead to improved treatment strategies. Topics will include nutrient access/use, aging, subcellular compartments, microenvironmental influences and tissue reprogramming.

Keywords: Cancer biology, molecular crosstalk, biochemical signaling, tissue homeostasis, aging, subcellular transport, local and global adaptations, tumor microenvironment.

Who should attend: Cancer researchers, cell biologists and biochemists interested in considering how aging, biochemistry and multi-scale adaptations cooperate to shape the stress landscapes of tumors.

Theme song: by A Tribe Called Quest

This session is powered by cortisol and catecholamines.

Stress adaptations in tumor progression

Jonathan Kelber (chair), Baylor University

Elda GrabockaThomas Jefferson University

Christina TowersSalk Institute for Biological Studies

Mark LaBargeBeckman Research Institute of City of Hope

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Jonathan A. Kelber
Jonathan A. Kelber

Jonathan A. Kelber is an associate professor of biology at Baylor University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.